Search

Aquesta publicació és un recull del treball realitzat pels estudiants i exestudiants d’EINA. Mitjançant una selecció de projectes, es mostra el rigor acadèmic i la capacitat d’anàlisi i experimentació que tenen els alumnes del Grau de Disseny i dels diferents Màsters i Postgraus d’EINA. Aquesta filosofia, que fomenta el potencial innovador del disseny i l’art, també es recull en la praxis professional que duen a terme els nostres alumni. Tots els projectes publicats són una síntesi de l’aprenentatge enriquidor, obert a diferents sistemes de pensament i llenguatges, amb què EINA treballa des de la seva fundació el 1967. Una metodologia en constant evolució a d’avançar-se a les necessitats i exigències de la nostra societat canviant, per poder donar resposta als nous reptes i fer realitat nous productes, nous serveis i noves experiències. En definitiva, aquesta publicació és el testimoni de la trajectòria de l’escola com a plataforma de cultura i coneixement de generacions de professionals del disseny i l’art que participen activament en el desenvolupament d’una societat més sostenible, ètica, reflexiva i compromesa. Esta publicación es una recopilación del trabajo realizado por los estudiantes y exestudiantes de EINA. Mediante una selección de proyectos se muestra el rigor académico y la capacidad de análisis y experimentación que tienen los alumnos del Grado de Diseño y de los diferentes Másters y Postgrados de EINA. Esta filosofía, que fomenta el potencial innovador del diseño y el arte, también se recoge en la praxis profesional que llevan a cabo nuestro alumni. Todos los proyectos publicados son una síntesis del aprendizaje enriquecedor, abierto a diferentes sistemas de pensamiento y lenguajes, con que EINA trabaja desde su fundación en 1967. Una metodología en constante evolución con el fin de adelantarse a las necesidades y exigencias de nuestra sociedad cambiante, para poder dar respuesta a los nuevos retos y hacer realidad nuevos productos, nuevos servicios y nuevas experiencias. En definitiva, esta publicación es el testimonio de la trayectoria de la escuela como plataforma de cultura y conocimiento de generaciones de profesionales del diseño y el arte que participan activamente en el desarrollo de una sociedad más sostenible, ética, reflexiva y comprometida. This publication is a collection of the work of EINA’s students past and present, a selection of projects from the Degree in Design and the various Masters’ and Postgraduate programmes, chosen for their academic rigor and analytic and experimental capacity. This foundation, which fosters the innovative potential of design and art, is also reflected in the professional practice of our alumni. All of the published projects are a synthesis of the enriching learning style, open to different systems of thought and language, which EINA has prioritized since its founding in 1967. It is a methodology in constant evolution, whose aim is to advance to meet the needs and demands of our changing society, so as to be able to respond to new challenges and make new products, new services and new experiences a reality. In short, this publication is witness to the trajectory of the school as the platform for knowledge and culture behind generations of art and design professionals who actively participate in the development of a more sustainable, ethical, thoughtful and committed society.

Mortality and ICU admission rates were 20.6% and 15.1%, respectively. The per-group analysis showed an increased prognosis for G3 (HR 0.59, 95%CI 0.36-0.95, p = 0.03) and G4 (HR 0.47, 95%CI 0.27-0.82, p = 0.007) vs. non-treated group (G1). Combined therapy was especially successful in those patients with the worst respiratory function (SpO2/FiO2 ratio ≤ 220) (HR 0.43, 95%CI 0.24-0.77, p = 0.004).

Background: Asthma is one of the most common non-communicable respiratory diseases, affecting about 6% of the general population. Severe asthma, even if afflicts a minority of asthmatics, drives the majority of costs of the disease. The aim of this study is to create a pharmacoeconomic model to predict the costs of corticosteroid-related adverse events in severe asthmatics and applying it to the first published epidemiologic data from the Severe Asthma Network in Italy (SANI) registry. Methods: The analysis was conducted from the perspective of the Italian National Healthcare System (INHS). Model inputs, derived from literature, included: asthma epidemiology data, frequency of adverse events, percentage of severe asthma treated with OCS and adverse event cost (Diagnosis-Related Group (DRG) national tariffs). We estimated costs per different patient groups: non-asthma controls, mild/moderate and severe asthmatics. Final results report estimated direct cost per patient and total direct cost for overall target population, showing economic impact related to corticosteroid complication. Results: Based on epidemiological data input, in Italy, asthmatic subjects resulted about 3,999,600, of which 199,980 with severe asthma. The number of patients with severe asthma OCS-treated was estimated at 123,988. Compared to the non-asthma control cohort and to that with moderate asthma annual cost per severe asthmatic patient resulted respectively about €892 and €606 higher, showing a corticosteroids shadow cost ranging from 45% to 30%.Applying the cost per patient to the target population identified for Italy, the budget impact model estimated a total annual cost related to OCS-related adverse events of €242.7 million for severe asthmatics. In respect with non-asthmatic and moderate population, an incremental expenditure of about € 110.6 million and €75.2, respectively, were shown. Conclusions: Our study provides the first estimates of additional healthcare costs related to corticosteroid induced adverse events in severe asthma patient. Budget impact model results highlighted the relevant economic impact of OCS-related adverse events in severe asthma patients. The future extrapolation of additional data from SANI registry will support the development of a model to investigate the role of corticosteroids sparing drugs. Keywords: Severe asthma, Oral corticosteroids, Adverse events, Pharmacoeconomy, Costs, Diabetes, Glaucoma, Obesity, Bone fracture, Chronic kidney disease

Background Severe Asthma Network in Italy (SANI) is a registry of patients recruited by accredited centers on severe asthma. Objective To analyze epidemiological, clinical, inflammatory, functional, and treatment characteristics of severe asthmatics from the SANI registry. Methods All consecutive patients with severe asthma were included into the registry, without exclusion criteria to have real-life data on demographics, asthma control, treatments (including biologics), inflammatory biomarkers, and comorbidities. Results A total of 437 patients (mean age: 54.1 years, 57.2% females, 70.7% atopics, 94.5% in Global Initiative for Asthma severity step V) were enrolled into the study. The mean annual exacerbation rate was 3.75. The mean blood eosinophil level was 536.7 cells/mcL, and the average serum total IgE was 470.3 kU/L. Approximately 64% of patients were on regular oral corticosteroid treatment, 57% with omalizumab and 11.2% with mepolizumab. Most common comorbidities were rhinitis, nasal polyposis, and bronchiectasis. Patients with nasal polyposis had higher age of disease onset, higher blood eosinophil count, and lower frequency of atopy and atopic eczema. Bronchiectasis was associated with more frequent severe exacerbations, higher blood eosinophils, and total IgE. Stratifying patients, those with late-onset asthma were less frequently atopic (with less frequent allergic rhinitis and food allergy), and more frequently with nasal polyposis and higher serum total IgE levels. Conclusions This study revealed a high frequency of relevant comorbidities and that a substantial proportion of patients have late-onset asthma; all these features define specific different disease phenotypes. Severe asthma complexity and comorbidities require multidisciplinary approaches, led by specifically trained pulmonologists and allergists.